SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001609351-18-000021
Filing Date
2018-02-23
Accepted
2018-02-23 18:11:27
Documents
2
Period of Report
2018-02-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_151942747330885.html 3  
1 FORM 3 wf-form3_151942747330885.xml 3 10697
2 LISA DALTON POA poaforlisadalton1.htm EX-24 32949
  Complete submission text file 0001609351-18-000021.txt   45040
Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Issuer) CIK: 0001609351 (see all company filings)

IRS No.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 3737 MARKET STREET, SUITE 1300 PHILADELPHIA PA 19104
Business Address
Dalton Lisa (Reporting) CIK: 0001732196 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36819 | Film No.: 18638063